cept Therapeutics rporated-Corcept Therapeutics (CORT) Q3 Earnings and Revenues Miss Estimates

Corcept Therapeutics (CORT) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of$ 0.18 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.11%. A quarter ago, it was expected that this drug developer would post earnings of$ 0.23 per share when it actually produced earnings of $0.29, delivering a surprise of +26.09%.Over the last four quarters ...